Skip to main content
Premium Trial:

Request an Annual Quote

NZMS, Invisible Sentinel Reach Veriflow Distribution Deal for New Zealand

NEW YORK (GenomeWeb) – New Zealand Medical and Scientific will distribute Invisible Sentinel's Veriflow assays in New Zealand under an agreement announced today.

NZMS will distribute Invisible Sentinel's product line of assays to detect food pathogens, including Veriflow LS for Listeria species; Veriflow SS for Salmonella species; Veriflow CA for Campylobacter; and Veriflow LM for Listeria monocytogenes. Auckland-based NZMS will also sell Veriflow BRETT, which is used to measure levels of Brettanomyces bruxellensis, a microbe that causes wine spoilage.

Veriflow assays for Escherichia coli 0157:H7 and Shiga toxin-producing E. coli are pending approval by the Association of Analytical Communities.

Financial and other terms of the deal were not disclosed.

"Having achieved market share in North America, we are now entering international markets as well," Invisible Sentinel Co-founder and CEO Nick Siciliano said in a statement. "We intend to grow our business both by applying the versatility of Veriflow technology for additional applications and by expanding our geographic reach."

Last month, the Philadelphia-based firm announced a partnership with Victory Brewing to improve beer production.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.